Mallinckrodt DRC A Multicenter, Open Label Pilot Study to Explore the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Severe Noninfectious Intermediate, Posterior, or Panuveitis
Research Grant
Administered By
Ophthalmology
Awarded By
Mallinckrodt Pharmaceuticals
Start Date
February 14, 2019
End Date
November 3, 2020
Administered By
Ophthalmology
Awarded By
Mallinckrodt Pharmaceuticals
Start Date
February 14, 2019
End Date
November 3, 2020